GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Cash Flow for Dividends

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Cash Flow for Dividends : ¥-1,197 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Cash Flow for Dividends?

Shandong Buchang Pharmaceuticals Co's cash flow for dividends for the three months ended in Mar. 2024 was ¥-33 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1,197 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shandong Buchang Pharmaceuticals Co's quarterly payment of dividends declined from Sep. 2023 (¥-1,107 Mil) to Dec. 2023 (¥-31 Mil) but then increased from Dec. 2023 (¥-31 Mil) to Mar. 2024 (¥-33 Mil).

Shandong Buchang Pharmaceuticals Co's annual payment of dividends declined from Dec. 2021 (¥-746 Mil) to Dec. 2022 (¥-547 Mil) but then increased from Dec. 2022 (¥-547 Mil) to Dec. 2023 (¥-1,194 Mil).


Shandong Buchang Pharmaceuticals Co Cash Flow for Dividends Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Cash Flow for Dividends Chart

Shandong Buchang Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -920.58 -2,488.23 -746.21 -547.34 -1,194.26

Shandong Buchang Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.50 -26.04 -1,106.98 -30.74 -33.43

Shandong Buchang Pharmaceuticals Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1,197 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Buchang Pharmaceuticals Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Traded in Other Exchanges
N/A
Address
No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000
Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines